Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayDec 14, 2022 9:45 am

Cepton, Inc. (NASDAQ: CPTN) Remains Committed to Improving Road Safety Through Development of Lidar Solutions for Assisted and Autonomous Driving

Nearly all automotive OEMs have plans to include lidar sensors within their assisted and automated driving platforms Gaining public trust in the ability of vehicles to operate safely while providing automated driving features will be a key milestone for widespread adoption L2+/L3 ADAS is likely to be an enabler as it helps ease the public with broader hands-free functions while maintaining the ability to take over as needed Cepton’s lidar sensors are uniquely positioned to benefit from these core industry growth trends and the Company remains committed to delivering superior driving experiences with added safety and convenience Automotive OEMs have…

Continue Reading

WednesdayDec 14, 2022 9:00 am

Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) Offers Solutions for Smart Businesses to Keep Making Cybersecurity a Priority

Cost-cutting becomes a priority for businesses looking to remain strong during record inflation “It’s always a question of what to prioritize and which costs to minimize while preserving the quality of your product,” states a Forbes article Cerberus ensures that companies not only stay more secure but also build a culture of cybersecurity In a fragile economy with a possible recession looming on the horizon, savvy companies are taking a close look at ways to tighten their belts. As they do so, a recent Forbes article cautions wise business leaders to keep cybersecurity in the forefront (https://nnw.fm/UoIvd), a strategy that…

Continue Reading

TuesdayDec 13, 2022 12:00 pm

Coyuchi Inc. Offers Gold Standard Luxury Home Goods to Satisfy Growing Market of Sustainability-Conscious Consumers

66% of US consumers (80% of consumers aged 18-34) are willing to pay more for products made with sustainability in mind The luxury home décor market is expected to reach $207 billion by 2027, growing from $118 billion in 2020 at a CAGR of 5.14% Coyuchi guarantees the highest environmental and ethical standards through its certifications - The Global Organic Textile Standard (“GOTS”), Fair Trade Certified, and MADE SAFE(R) Coyuchi is built upon four foundational pillars – protecting the environment, innovating circular design, living sustainably, and enriching the community – with over 1400 SKUs made from 100% organic cotton The…

Continue Reading

TuesdayDec 13, 2022 11:15 am

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Unveils Commercial Prototype of its ZVS Inverter Technology

Hillcrest Energy Technologies recently unveiled a commercial prototype of its 800-volt, 250-kilowatt Zero Voltage Switching (“ZVS”) traction inverter The production of a commercial prototype comes only months after the company had published white papers, extolling the potential of their revolutionary technology The inverter will be developed and integrated alongside Hillcrest’s partners, Hercules Electric Mobility as well as a separate Tier 1 automotive supplier The company envisions its inverter technology being deployed with batteries, electric motors, generators, fuel cells and any other power source requiring power conversion Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF), a clean technology company focused on developing…

Continue Reading

TuesdayDec 13, 2022 10:30 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 2022 Calendar Year in Review

Lexaria Bioscience is a global innovator in drug delivery platforms whose patented DehydraTECH(TM) technology has demonstrated the ability to improve the bioavailability and increase the speed of onset of many drugs In calendar 2022, the company achieved a number of milestones in various areas, including research programs, receipt of patents, and licensing agreements Lexaria started and completed its fourth and most comprehensive hypertension study yet, investigating the capabilities of DehydraTECH-CBD, with the study showing that its formulation resulted in a sustained reduction in blood pressure over the study period (five weeks) The company has also started investigating DehydraTECH-CBD as a…

Continue Reading

TuesdayDec 13, 2022 9:45 am

SideChannel Inc. (SDCH) Brings On Principal Consultant to Provide Top-Tier Security Guidance at Manageable Cost

SideChannel is a company making cybersecurity accessible and simple, especially for small and mid-sized businesses (“SMBs”) The company provides cybersecurity services in the form of virtual CISOs (“vCISOs”), engineering services that enable the vCISOs to provide operational day-to-day security and privacy to clients, and proprietary security software called Enclave SideChannel’s differentiator from its competition is its team of experts, and recently the company hired IT and cybersecurity veteran Sean Higgins as Principal Consultant In this role, Sean will help client companies’ CISOs and senior management evaluate and have greater levels of confidence in their security programs SideChannel (OTCQB: SDCH), a…

Continue Reading

TuesdayDec 13, 2022 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Innovative Inhaled COVID-19 NanoAb Therapy Shows Statistically Significant Efficacy Results in Preclinical Study

The NanoAbs may provide improve upon existing treatments such as Paxlovid, which has several contraindications The company’s pipeline of alpaca-derived NanoAb therapies aims to address diseases with large underserved medical needs, including COVID-19, asthma, psoriasis, and more The global COVID-19 therapy market was valued at $16.8 billion in 2021 and is expected to grow at a CAGR of 20%, resulting in a value of $35.42 billion by 2025 A study recently published in JAMA Network found that nearly 15% of COVID-19 patients admitted to 36 Paris University hospitals had contraindications (excluding factors) to Paxlovid, the leading COVID-19 treatment. While Paxlovid…

Continue Reading

MondayDec 12, 2022 12:00 pm

REZYFi, Inc. to Benefit as Marijuana Sales Projected to Hit $53 Billion by 2026

Marijuana sales are projected to hit $33 billion in 2022, up from $3 billion in 2015, and are on track to hit $53 billion by 2026 REZYFi, a growth mortgage origination and specialized financing company, with target markets including the legalized cannabis industry, is set to be one of the key beneficiaries in this anticipated growth With the ongoing conversation around marijuana, along with the bipartisan support for its legalization, the company is optimistic that the demand for its products and services will see a spike as time progresses REZYFi still believes that financing options for cannabis-related firms will continue…

Continue Reading

MondayDec 12, 2022 11:15 am

Correlate Infrastructure Partners Inc. (CIPI) at the Forefront of Energy Transition, Making Clean Energy Affordable and Accessible

Residential solar power installations posted a 34% growth from 2.9 gigawatts in 2020 to 3.9 gigawatts in 2021. In addition, 17.6 gigawatts of new utility-scale solar capacity came online between June 2021 and June 2022 This growth has been linked to the falling cost of solar power infrastructure, with solar PV posting a 70% drop since 2014 Correlate has seen a notable spike in demand for its products and services in recent months and is currently executing a $200 million project pipeline Through its finance platform, the company is making proprietary technology available to interested parties, and through its unique…

Continue Reading

MondayDec 12, 2022 10:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Has Potential to Make History in Battle Against Deadly Brain Cancer with Berubicin

Glioblastoma, also known as GBM, is a fatal and incurable brain cancer that tends to recur aggressively after initial treatment CNS Pharmaceuticals is a U.S.-based pharmaceutical innovator whose flagship drug candidate, Berubicin, is a potentially pivotal treatment for treating GBM because of its novel apparent ability to cross the blood-brain barrier at effective levels CNS is building upon prior clinical trial outcomes with its global potentially pivotal trial currently registering patients in the United States and Europe Berubicin’s development is being advanced with potential time and cost savings thanks to the FDA’s decision to grant it Fast Track and Orphan…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000